Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency
Abstract
:1. Introduction
2. Materials and Methods
2.1. Animals
2.2. Animal Procedures
2.3. The Treatment Experiment
2.4. The Breeding Experiment
2.5. Experiment Timeline
2.6. Statistical Analysis
3. Results
3.1. UCMSCs Effect on Body Weight
3.2. UCMSCs Recover Ovarian Secretory Functions
3.3. UCMSCs Rescue Ovarian Excretory Function (Ovulation)
4. Discussion
Author Contributions
Funding
Conflicts of Interest
References
- Panay, N.; Fenton, A. Premature ovarian failure: A growing concern. Climacteric 2008, 11, 1–3. [Google Scholar] [CrossRef] [PubMed]
- Zhu, S.F.; Hu, H.B.; Xu, H.Y.; Fu, X.F.; Peng, D.X.; Su, W.Y.; He, Y.L. Human umbilical cord mesenchymal stem cell transplantation restores damaged ovaries. J. Cell Mol. Med. 2015, 19, 2108–2117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fazeli, Z.; Abedindo, A.; Omrani, M.D.; Ghaderian, S.M.H. Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: A Systematic Review. Stem Cell Rev. 2018, 14, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Elfayomy, A.K.; Almasry, S.M.; El-Tarhouny, S.A.; Eldomiaty, M.A. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effects. Tissue Cell 2016, 48, 370–382. [Google Scholar] [CrossRef] [PubMed]
- Podfigurna-Stopa, A.; Czyzyk, A.; Grymowicz, M.; Smolarczyk, R.; Katulski, K.; Czajkowski, K.; Meczekalski, B. Premature ovarian insufficiency: The context of long-term effects. J. Endocrinol. Investig. 2016, 39, 983–990. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Luo, Q.; Lu, X.; Yin, N.; Zhou, D.; Zhang, L.; Zhao, W.; Wang, D.; Du, P.; Hou, Y.; et al. Effects of hPMSCs on granulosa cell apoptosis and AMH expression and their role in the restoration of ovary function in premature ovarian failure mice. Stem Cell Res. Ther. 2018, 9, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sassarini, J.; Lumsden, M.A.; Critchley, H.O. Sex hormone replacement in ovarian failure—New treatment concepts. Best Pract. Res. Clin. Endocrinol. Metab. 2015, 29, 105–114. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Wang, Y.; Yang, T.; Li, J.; Yang, X. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res. Ther. 2017, 8, 11. [Google Scholar] [CrossRef]
- Chen, L.; Guo, S.; Wei, C.; Li, H.; Wang, H.; Xu, Y. Effect of stem cell transplantation of premature ovarian failure in animal models and patients: A meta-analysis and case report. Exp. Ther. Med. 2018, 15, 4105–4118. [Google Scholar] [CrossRef]
- Mohamed, S.A.; Shalaby, S.M.; Abdelaziz, M.; Brakta, S.; Hill, W.D.; Ismail, N.; Al-Hendy, A. Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure. Reprod. Sci. 2018, 25, 51–63. [Google Scholar] [CrossRef]
- Wang, M.; Yang, Y.; Yang, D.; Luo, F.; Liang, W.; Guo, S.; Xu, J. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009, 126, 220–232. [Google Scholar] [CrossRef] [PubMed]
- Myers, M.; Britt, K.L.; Wreford, N.G.M.; Ebling, F.J.P.; Kerr, J.B. Methods for quantifying follicular numbers within the mouse ovary. Reproduction 2004, 127, 569–580. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kalu, E.; Panay, N. Spontaneous premature ovarian failure: Management challenges. Gynecol. Endocrinol. 2009, 24, 273–279. [Google Scholar] [CrossRef]
- Cecconi, S.; Ciccarelli, C.; Barberi, M.; Macchiarelli, G.; Canipari, R. Granulosa cell-oocyte interactions. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 115 (Suppl. 1), S19–S22. [Google Scholar] [CrossRef] [PubMed]
- Sheikhansari, G.; Aghebati-Maleki, L.; Nouri, M.; Jadidi-Niaragh, F.; Yousefi, M. Current approaches for the treatment of premature ovarian failure with stem cell therapy. Biomed. Pharmacother. 2018, 102, 254–262. [Google Scholar] [CrossRef] [PubMed]
- Abd-Allah, S.H.; Shalaby, S.M.; Pasha, H.F.; Amal, S.; Raafat, N.; Shabrawy, S.M.; Awad, H.A.; Amer, M.G.; Gharib, M.A.; El Gendy, E.A.; et al. Mechanistic action of mesenchymal stem cell injection in the treatment of chemically induced ovarian failure in rabbits. Cytotherapy 2013, 15, 64–75. [Google Scholar] [CrossRef] [PubMed]
- Asgari, H.R.; Akbari, M.; Yazdekhasti, H.; Rajabi, Z.; Navid, S.; Aliakbari, F.; Abbasi, N.; Aval, F.S.; Shams, A.; Abbasi, M. Comparison of Human Amniotic, Chorionic, and Umbilical Cord Multipotent Mesenchymal Stem Cells Regarding Their Capacity for Differentiation Toward Female Germ Cells. Cell Reprogram. 2017, 19, 44–53. [Google Scholar] [CrossRef]
- Park, J.H.; Hwang, I.; Hwang, S.H.; Han, H.; Ha, H. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res. Clin. Pract. 2012, 98, 465–473. [Google Scholar] [CrossRef]
- Ding, C.; Li, H.; Wang, Y.; Wang, F.; Wu, H.; Chen, R.; Lv, J.; Wang, W.; Huang, B. Different therapeutic effects of cells derived from human amniotic membrane on premature ovarian aging depend on distinct cellular biological characteristics. Stem Cell Res. Therapy 2017, 8, 173. [Google Scholar] [CrossRef]
- Li, J.; Mao, Q.; He, J.; She, H.; Zhang, Z.; Yin, C. Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism. Stem Cell Res. Ther. 2017, 8, 55. [Google Scholar] [CrossRef]
- Wang, S.; Yu, L.; Sun, M.; Mu, S.; Wang, C.; Wang, D.; Yao, Y. The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. Biomed. Res. Int. 2013, 2013, 690491. [Google Scholar] [CrossRef] [PubMed]
- Blumenfeld, Z. Chemotherapy and fertility. Best Pract. Res. Clin. Obstet. Gynaecol. 2012, 26, 379–390. [Google Scholar] [CrossRef]
- Ishige, I.; Nagamura-Inoue, T.; Honda, M.J.; Harnprasopwat, R.; Kido, M.; Sugimoto, M.; Nakauchi, H.; Tojo, A. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord. Int. J. Hematol. 2009, 90, 261–269. [Google Scholar] [CrossRef] [PubMed]
- Forraz, N.; McGuckin, C.P. The umbilical cord: A rich and ethical stem cell source to advance regenerative medicine. Cell Prolif. 2011, 44 (Suppl. 1), 60–69. [Google Scholar] [CrossRef] [PubMed]
- Song, D.; Zhong, Y.; Qian, C.; Zou, Q.; Ou, J.; Shi, Y.; Gao, L.; Wang, G.; Liu, Z.; Li, H.; et al. Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model. Biomed. Res. Int. 2016, 2016, 2517514. [Google Scholar] [CrossRef] [PubMed]
- Ayuandari, S.; Winkler-Crepaz, K.; Paulitsch, M.; Wagner, C.; Zavadil, C.; Manzl, C.; Ziehr, S.C.; Wildt, L.; Hofer-Tollinger, S. Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: Dynamics and molecular aspects. J. Assist. Reprod. Genet. 2016, 33, 1585–1593. [Google Scholar] [CrossRef] [PubMed]
- Ertl, J.; Pichlsberger, M.; Tuca, A.C.; Wurzer, P.; Fuchs, J.; Geyer, S.H.; Maurer-Gesek, B.; Weninger, W.J.; Pfeiffer, D.; Bubalo, V.; et al. Comparative study of regenerative effects of mesenchymal stem cells derived from placental amnion, chorion and umbilical cord on dermal wounds. Placenta 2018, 65, 37–46. [Google Scholar] [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mohamed, S.A.; Shalaby, S.; Brakta, S.; Elam, L.; Elsharoud, A.; Al-Hendy, A. Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency. Biomedicines 2019, 7, 7. https://doi.org/10.3390/biomedicines7010007
Mohamed SA, Shalaby S, Brakta S, Elam L, Elsharoud A, Al-Hendy A. Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency. Biomedicines. 2019; 7(1):7. https://doi.org/10.3390/biomedicines7010007
Chicago/Turabian StyleMohamed, Sara A., Shahinaz Shalaby, Soumia Brakta, Lelyand Elam, Amro Elsharoud, and Ayman Al-Hendy. 2019. "Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency" Biomedicines 7, no. 1: 7. https://doi.org/10.3390/biomedicines7010007
APA StyleMohamed, S. A., Shalaby, S., Brakta, S., Elam, L., Elsharoud, A., & Al-Hendy, A. (2019). Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency. Biomedicines, 7(1), 7. https://doi.org/10.3390/biomedicines7010007